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Abstract
Cytoglobin is an intracellular globin of unknown function that is expressed mostly in cells of a myofibroblast lineage.
Possible functions of cytoglobin include buffering of intracellular oxygen and detoxification of reactive oxygen species.
Previous work in our laboratory has demonstrated that cytoglobin affords protection from oxidant-induced DNA damage
when over expressed in vitro, but the importance of this in more physiologically relevant models of disease is unknown.
Cytoglobin is a candidate for the tylosis with oesophageal cancer gene, and its expression is strongly down-regulated in
non-cancerous oesophageal biopsies from patients with TOC compared with normal biopsies. Therefore, oesophageal cells
provide an ideal experimental model to test our hypothesis that downregulation of cytoglobin expression sensitises cells to
the damaging effects of reactive oxygen species, particularly oxidative DNA damage, and that this could potentially
contribute to the TOC phenotype. In the current study, we tested this hypothesis by manipulating cytoglobin expression in
both normal and oesophageal cancer cell lines, which have normal physiological and no expression of cytoglobin
respectively. Our results show that, in agreement with previous findings, over expression of cytoglobin in cancer cell lines
afforded protection from chemically-induced oxidative stress but this was only observed at non-physiological
concentrations of cytoglobin. In addition, down regulation of cytoglobin in normal oesophageal cells had no effect on
their sensitivity to oxidative stress as assessed by a number of end points. We therefore conclude that normal physiological
concentrations of cytoglobin do not offer cytoprotection from reactive oxygen species, at least in the current experimental
model.
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Introduction
Cytoglobin is a member of the globin family of haemoproteins
that include haemoglobin and myoglobin, as well as the more
recently identified neuroglobin that is expressed mainly in cells of
the CNS [1]. The crystal structure of cytoglobin has been solved
and studied in detail [2,3,4] showing that cytoglobin has many
similarities to other globins, including the classic three-over-three
alpha helical globin fold and a PO2 (oxygen affinity) of
approximately 0.2 Torr, similar to that of myoglobin [e.g. 5,6].
The high affinity of cytoglobin for oxygen has led to the suggestion
that cytoglobin may serve as an ‘‘intracellular’’ oxygen transport
system. In this scenario, cytoglobin is proposed to deliver oxygen
to the mitochondria to sustain oxidative phosphorylation, in a
manner similar to the function of myoglobin in muscle cells.
Interestingly, oxygen affinity appears to be redox-sensitive, and
regulated by the formation of a disulphide bridge between two
external cysteine residues (Cys B2 and Cys E9). The redox-
sensitive nature of cytoglobin oxygen affinity suggests a possible
role of cytoglobin as an oxygen ‘‘sink/reserve’’, whereby oxygen is
only released when cells become hypoxic. Although these are
attractive hypotheses, cytoglobin expression appears to be largely
limited to cells of a fibroblast origin with no apparent correlation
between metabolic activity of tissues and levels of cytoglobin
expression which, in any case, is rather low in most cell types
investigated [7,8]. These findings have led to the search for
alternative physiological function(s) for cytoglobin.
Cytoglobin was first identified in 2001 [9] during a proteomic
screen of hepatic stellate cells isolated from fibrotic rat liver tissue
and indeed was originally named stellate cell activation association
protein (STAP) in recognition of that fact [9]. Subsequent work –
both in vitro and in vivo [10–13], most recently using transgenic
animals over-expressing cytoglobin [14,15] appear to confirm that
cytoglobin plays a role in the fibrotic response in a number of
organs including the liver and kidney. Although the precise role of
cytoglobin in fibrosis remains to be established, pertubation of
redox homeostasis is a well characterised feature of fibrosis and
there is good evidence (particularly with regards lung and kidney)
that progression of fibrotic lesions involves cycles of oxidative
reperfusion injury subsequent to tissue hypoxia. Furthermore, it
has been demonstrated that cytoglobin expression can be
upregulated by hypoxia [16–19]. Therefore it seems likely that
cytoglobin is involved in the adaptive response associated with this
injury.
Related to the findings in fibrotic disease, there is also an
emerging body of mechanistic evidence to suggest that cytoglobin
may afford protection from oxidative cellular injury under other
circumstances, possibly as a result of its ability to scavenge reactive
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oxygen species [20–23]. Indeed, work in our own laboratory has
shown that overexpression of cytoglobin reduces levels of
chemically-induced reactive oxygen species (ROS) and affords
protection from pro-oxidant induced injury (lipid peroxidation and
oxidative DNA strand breaks) [24]. In further support for a role in
detoxification of ROS, it has been reported that cytoglobin has
peroxidase activity [9]. Interestingly, more recently it has been
reported that ferric cytoglobin has pseudo-peroxidase activity
against lipids, suggesting that, under conditions of oxidative stress,
turnover of lipid based cell signalling molecules may also be part of
a cytoglobin-dependent antioxidant response [25]. Furthermore,
another vertebrate globin, globin X, has been found to be
membrane associated and possibly involved in protection of lipids
from oxidation [26].
Intriguingly, in addition to the possible roles discussed above,
the cytoglobin gene (CYGB) is also a candidate tumour suppressor
gene [27,28,29]and we have identified CYGB as a candidate tylosis
with oesophageal cancer (TOC) gene [30–33]. Although CYGB is
not mutated in tylotic individuals [31] or in a series of sporadic
squamous cell oesophageal carcinomas [34], we have shown that
its expression is strongly downregulated in non-cancerous
oesophageal biopsies from patients with TOC compared with
normal biopsies [33]. CYGB is also methylated and downregulated
in sporadic oesophageal, lung and head and neck cancers
[27,28,33]. Recently, downregulation of cytoglobin has also been
shown to promote chemically induced carcinogenesis in rodent
liver [35].
There is compelling evidence that oxidative damage to DNA
(e.g. 8-oxo deoxyguanosine), if not repaired, contributes to the
formation of mutations that are known to be important in the
aetiology of human carcinogenesis [36,37]. We therefore hypothe-
sise that loss of cytoglobin expression would render oesophageal
cells more susceptible to the damaging effects of ROS, and that
this contributes to the observed phenotype of TOC. In the current
study we tested this hypothesis by manipulating cytoglobin
expression in both normal oesophageal epithelial cells and
oesophageal squamous cell carcinoma cells, which have normal
physiological and no endogenous expression of cytoglobin,
respectively.
Results
Manipulation of cytoglobin expression
Real time RT-PCR showed that the TE-8 squamous cell
oesophageal cancer cell line has extremely low endogenous levels
of CYGB expression (lower than 1025 with respect to beta actin
(ACTB)), whereas NE1 normal oesophageal keratinocytes express
CYGB at approximately 0.16ACTB. This natural level of CYGB
expression in NE1 cells was deemed to be the normal physiological
level, as it is within the same order of magnitude as that observed
in a panel of normal tissues (data not shown). CYGB expression
was modulated in these two cell lines by either transient
transfection of the gene (TE-8 cells) or transient knockdown using
RNA interference (NE1 cells). Cytoglobin expression was
artificially induced by approximately 4 or 7 orders of magnitude
in TE-8 cells, and was reduced by approximately five-fold by
siRNA knockdown in NE1 cells (Figure 1).
Characterisation of cells
Normal oesophageal epithelial (NE-1) and oesophageal cancer
(TE-8) cells were assayed for levels of oxidative stress using the
redox-sensitive compound 29,79-dichlorodihydrofluorescein diace-
tate (H2DCF-DA) in the presence and absence of buthionine
sulfoxamine (BSO).
The results indicated that BSO was able to induce oxidative
stress in both TE-8 and NE1 cell lines, with a concentration-
Figure 1. Quantification of CYGB expression in oesophageal cells subjected to transient transfection or siRNA knockdown. Levels of
CYGB expression, compared to ACTB expression, were determined by real time RT-PCR in a parallel sample for each comet assay performed. These
expression levels therefore relate directly to the comet assay data presented in Figure 3. The geometric mean of all experiments is shown for both TE-
8 cells (orange bars) and NE1 cells (pink bars).
doi:10.1371/journal.pone.0030587.g001
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dependent response being evident (Figure 2). In TE-8 cells, this
reached statistical significance in unmanipulated cells (p = 0.0134)
and CYGB transfected cells (p = 0.0034), but not in mock
transfected cells (p = 0.092). Nevertheless, a similar trend was
observed in mock transfected cells. In the normal oesophageal cell
line NE1, similar results were obtained: in this instance the BSO
concentration-dependent oxidative stress response was statistically
significant in all three groups of cells. BSO was able to induce
oxidative stress in control cells (p = 0.0032), negative control
siRNA treated cells (p = 0.0283), and cells subjected to siRNA
knockdown of CYGB (p= 0.0077). Although a trend was observed
in TE-8 cells towards overexpression of CYGB being associated
with lower levels of ROS when compared with mock transfected
cells, this was not statistically significant. No effect of CYGB
knockdown was observed in NE1 cells. However, as our primary
question was to look at ROS-associated DNA damage, and not
oxidative stress per se, we next performed the comet assay on the
two cell lines: this has the additional benefit of being a much more
sensitive indicator of cellular oxidative damage.
Relationship between oxidative DNA damage and
cytoglobin expression
Comet Assay. In TE-8 cells, CYGB expression was
artificially restored by transient transfection (Figure 1). Oxidative
DNA damage was measured by the comet assay in cells with two
different levels of CYGB expression in addition to the baseline
controls: artificially high overexpression (approximately 102–fold
with respect to ACTB expression), and low (roughly physiological)
expression (approximately 1021–fold with respect to ACTB
expression). At artificially high levels of CYGB expression, a
significant reduction in oxidative DNA damage was observed
under conditions of exogenous oxidative stress (1000 mM BSO)
(p = 0.014) when compared to mock-transfected cells (Figure 3a)
There was also a significant difference in oxidative DNA damage
between cells with low/physiological and high CYGB expression
levels (p = 0.035). However, there was no significant difference
between mock-transfected cells and those with low/physiological
CYGB expression levels (p = 0.074); similarly no difference was
observed between control and mock-transfected cells (p = 0.455).
These data suggest that CYGB exerts a protective effect against
cellular oxidative damage only at artificially high – non-
physiological levels of expression. Although, counter-intuitively,
there was a trend towards increased oxidative DNA damage when
CYGB was expressed at low/physiological levels, this trend did
not reach statistical significance. In NE1 cells, reduction of CYGB
expression by 90% using RNA interference did not result in any
difference in oxidative DNA damage: this further supports the
argument that CYGB only exerts its cytoprotective effects at
artificially high (non-physiological) levels of expression (figure 3b).
Cytoglobin and cell motility
Previous studies have shown that cytoglobin influences cellular
motility and colony forming ability [29], however in the current
study no effect of cytoglobin knockdown upon cell growth was
detected in either NE1 oesophageal keratinocytes or CCD-18Co
colonic myofibroblasts, at either 25 or 50 hours post-wounding
(data not shown).
Discussion
Previous work in our and other laboratories has shown that
cytoglobin has the potential to detoxify reactive oxygen species
(ROS) in vitro when overexpressed in various cell culture systems
[20,21,22,24]. Furthermore, downregulation of cytoglobin by
RNAi has also recently been shown to sensitise glioma cells to
oxidative stress, induced by both inhibition of the electron
transport chain with antimycin A, and ionizing radiation [23].
Further support for a role for cytoglobin in detoxification of ROS
is the biochemical evidence that the cytoglobin protein possesses
intrinsic peroxidase activity as well as antioxidant properties and
there is evidence that other globins including neuroglobin and
globin X may also have similar properties [20,26,38,39]. However,
in the case of cytoglobin, it remains uncertain whether this is a
genuine physiological function of cytoglobin or an artifact of the
experimental models used. To date, no ‘‘cytoglobin reductase’’ has
been identified that could reduce the Fe3+ back to Fe2+, so it is not
clear how oxidised cytoglobin would be recycled within cells.
There is also evidence that cytoglobin has catalytic activity against
the reactive nitrogen species nitric oxide, catalysing its conversion
to nitrate where ascorbate and cytochrome b(5) have been
identified as potential sources of reducing power [40]. This
putative activity correlates well with the observation of high levels
of cytoglobin expression in fibroblasts and smooth muscle cells of
the vasculature, where nitric oxide is a well-known signalling
molecular that mediates vascular tone [41]. However, other
studies have questioned whether nitric oxide dioxygenase is a
physiologically relevant enzymic activity of cytoglobin [42]. In
addition, there is also emerging in vivo evidence of a protective role
of cytoglobin (and neuroglobin) against oxidative stress, especially
in models of fibrosis that involve hypoxic reperfusion and
subsequent oxidative injury [10–15].
Much of these data have been generated in experimental
models where cytoglobin is over-expressed, so although these are
interesting findings, their physiological relevance remains unclear.
In the current study, we investigated whether cytoglobin
expression could afford protection from chemically-induced
oxidative DNA damage in cultured oesophageal cells. This is
particularly pertinent because CYGB is down regulated in both
tylosis with oesophageal cancer and sporadic oesophageal cancers
[33] and we therefore hypothesised that loss of cytoglobin
expression would sensitise these cells to DNA damage and that
this may be involved in the aetiology of oesophageal cancer. When
cytoglobin was overexpressed in TE-8 oesophageal cancer cell
lines, which have little or no endogenous cytoglobin expression,
consistent with previous studies we observed statistically significant
protection from BSO-induced oxidative DNA damage as assessed
by the FPG-modified comet assay. This effect however was
concentration-dependent: at lower levels of cytoglobin overex-
pression the protective effect was lost. Consistent with this,
knockdown of physiological levels of cytoglobin in cultures of
primary NE1 oesophageal cells did not sensitise them to BSO-
induced oxidative DNA damage as assessed by the same endpoint.
Interestingly, it has recently been reported that knockdown of
cytoglobin expression in glioma cells by RNAi elevates levels of
antimycin A-induced hydrogen peroxide [23]. In the current
study, we observed no significant difference in levels of BSO-
induced oxidative stress as assessed by oxidation of dichlorofluor-
oscein. The reason for this difference is not clear but may be
related to either the different cell line or method to induce
oxidative stress.
Our findings suggest that although induction of cytoglobin
expression,for example as a result of hypoxia or in response to
oxidative injury, has the potential to be protective, in our study this
was only observed at CYGB levels unlikely to be achieved in vivo.
Furthermore, there was no evidence of an increased sensitivity to
ROS following knockdown by RNAi in cells expressing cytoglobin
at physiological levels. Therefore, a cytoprotective role against
oxidatively induced DNA damage does not appear to be a
Cytoglobin and Oxidative Stress
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function of cytoglobin in oesophageal cells and other explanations




Normal oesophageal epithelial cells (NE-1, A gift of Professor
G.S.W Tsao, Department of Anatomy, University of Hong Kong
(see [43]) were maintained in T75 culture flasks using keratinocyte
serum free media (Gibco) supplemented with bovine pituitary
extract (25 mg ml21) and recombinant epidermal growth factor
(0.15 ng ml21). Cultures were routinely split 1:3 approximately
every 3–4 days using trypsin-EDTA and soybean trypsin inhibitor
(Gibco) according to the recommended protocol for the keratino-
cyte serum-free medium. The oesophageal cancer cell line TE-8 (A
gift of Professor Toshio Kudo, Cell Resource Centre for
Biomedical Research, Tohoku University, Japan, [44]) was grown
in T75 culture flasks with RPMI medium supplemented with 10%
FBS and 2% L-Glutamine. TE-8 cells were split as necessary using
a standard trypsin-EDTA protocol. CCD-18Co colonic myofibro-
blasts (purchased from ATCC product no: CRL-1459; [45]) were
grown in DMEM supplememented with 10% FBS, 1% L-
glutamine and 1% non-essential amino acids (NEAAs). These
cells were spilt as necessary using a standard trypsin-EDTA
protocol.
Cytoglobin knockdown
NE-1 cells or CCD-18Co cells were subcultured into six-well
plates (for comet assay) or twelve-well plates (for ROS assay and
wound-healing assay), and allowed to reach 60–70% confluence
prior to transfection. Cells were transfected with 25 nM final
Figure 2. Impact of BSO treatment and CYGB expression on oxidative stress response. Oxidative stress was measured in a: TE-8 and b:
NE1 cells. Median DCF fluorescence is the mean of 5 repeats. All values were normalised to the level seen in the control cells with no BSO. Error bars
represent SEM.+2020: transfection reagent only; +CYGB: cells transfected with full length CYGB;2ve siRNA: scrambled control; CYGB k/d: CYGB siRNA.
* Statistically significant concentration-dependent response (p,0.05) ** Statistically significant concentration-dependent response (p,0.01).
doi:10.1371/journal.pone.0030587.g002
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concentration of either a negative control scrambled siRNA
(Ambion; AM4611) or CYGB siRNA (Qiagen; SI03228323 or
Ambion; s41571) using 15 mg ml21 TransIT siQuest reagent
(Mirus Bio) according to the manufacturer’s instructions. Follow-
ing RNAi knockdown, cells were incubated for 42 hours before
carrying out experiments (24 hours for wound-healing experi-
ment). Expression of CYGB was assayed by RT-PCR (see below).
Overexpression of cytoglobin
TE-8 oesophageal squamous cell carcinoma cells were subcul-
tured into six- or twelve-well plates as previously. Transient
transfection of CYGB was accomplished with Transit 2020
transfection reagent (Mirus Bio) (2 ml or 5 ml per well for 12-well
or 6-well plates respectively), and full length CYGB cDNA clone in
a pCMV6-AC vector (Origene) (0.6 mg or 1.5 mg for 12-well or 6-
well plates respectively), as per the standard protocol for the
transfection reagent. Following transfection, cells were incubated
for 42 hours before carrying out experiments. Expression of
CYGB was assayed by RT-PCR (see below).
RNA extraction, first strand cDNA synthesis and RT-PCR
analysis
Isolation of total RNA was carried out using an RNeasy Minikit
(Qiagen) with direct lysis of the cells in the culture plate, and
homogenization using QiaShredder tubes. Reverse transcription
was performed using a RETROscript Kit (Ambion) with, oligo dT
primers and 1 mg of total RNA, according to the manufacturer’s
instructions. For RT-PCR a master mix was prepared containing
TaqMan 26master mix (Applied Biosystems), b-actin VIC/MGB
probe for the endogenous control (Applied Biosystems 4326315E),
CYGB primer and probe mix (sense 59-CTC TAT GCC AAC
TGC GAG GAC-39, anti-sense 59-AAC TGG CTG AAG TAC
Figure 3. Impact of BSO treatment and CYGB expression upon Oxidative DNA damage. DNA strand-breaks (baseline and oxidative-
damage-induced) were measured by the Fpg-modified comet assay in a: TE-8 and b: NE-1 cells with different levels of CYGB expression (as shown in
Figure 1). Mean of median percent comet tail intensity is shown. Error bars represent SEM. * Significantly different from each other (p,0.05). #
Significantly different from each other (p,0.05).
doi:10.1371/journal.pone.0030587.g003
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TGC TTG-39 and probe FAM-59-TGG CCA TCC TGG TGA
GGT TCT TTG TG-39-black hole quencher) in RNase-free
water. A standard two-step protocol was employed for real time
RT-PCR analysis (50uC for 2 minutes, followed by 50 cycles of
95uC for 15 minutes and 60uC for 1 minute). The Cycle
Threshold (Ct) values obtained were used to calculate the real-
time quantification value (RQ) utilising the DDCt method, with
ACTB Ct values and untreated/untransfected cells used as the
normalisation factors.
FPG modified comet assay
The method was based on that of Singh et al [46] with minor
modifications [47]. Following treatment, cells were washed in cold
PBS and gently scraped into 1 ml fresh PBS (TE-8 cells) or
trypsinised (NE1 cells). Following centrifugation (8000 rpm,
5 minutes) pellets were re-suspended in PBS (150 ml). An aliquot
of re-suspended cells (30 ml) was placed into a sterile tube
containing low melting point agarose (300 ml) and this cell
suspension was transferred to two glass microscope slides (150 ml
per slide), pre-coated with 0.5% normal melting point agarose.
Glass coverslips were added and slides placed on a metal tray over
ice for 10 minutes. Coverslips were removed and slides incubated
for 1 h at 4uC in lysis buffer (2.5 M NaCl, 0.1 M Na2EDTA,
10 mM Tris base, 1% sodium N - lauryl sarcosinate, 10% DMSO
and 1% Triton X-100). Slides were washed (365 minutes) with
FPG Buffer (40 mM HEPES, 0.1 M KCl, 0.5 mM EDTA
0.2 mg/ml bovine serum albumin pH 8.0) and incubated with 1
unit of FPG enzyme (Trevigen) in 50 ml FPG buffer at 37uC for
1 hour (control slides were incubated with FPG buffer only). Slides
were transferred to a horizontal electrophoresis tank containing
electrophoresis buffer (300 mM NaOH and 1 mM Na2EDTA,
pH 13.0) and DNA allowed to unwind for 20 minutes. DNA was
subjected to electrophoresis (25 V, 0.8 V cm21, 20 minutes) and
slides neutralised by washing (365 minutes) with neutralisation
buffer (0.4 M Tris, adjusted to pH 7.5). Slides were subsequently
stained with Sybr Gold 50 ml (Invitrogen, 106 solution in
neutralisation buffer).
The slides were examined at 3206 magnification using a
fluorescence microscope (Zeiss Axiovert 10, Germany), fitted with
a 515–560 nm excitation filter and a barrier filter of 590 nm. A
USB digital camera (Merlin, Allied Vision Technologies) received
the images, which were analysed using a personal computer-based
image analysis system Comet assay IV (Perceptive instruments).
Images of one hundred randomly selected nuclei were analysed
per slide. Measurement of percent tail DNA (TD %) was chosen to
assess the extent of DNA damage as this has been shown to suffer
much less from inter-run variation than other comet parameters
because it is largely independent of electrophoresis voltage and run
time [48]. Median values of three separate experiments were
analysed using ANOVA and post-hoc Student’s t-test, as
recommended by Duez et al [49].
ROS assay
Reactive oxygen species were assessed by measuring the
oxidation of the redox sensitive dye 29,79-dichlorodihydrofluor-
escein diacetate (H2DCF-DA). Following hydrolysis by intracel-
lular esterases, the resultant H2DCF is unable to leave the cell and
is then oxidized by ROS to form the fluorescent DCF molecule.
The level of fluorescence is proportional to the degree of oxidative
stress in the cells. In order to induce oxidative stress artificially,
buthionine sulfoximine (BSO), which inhibits the rate-limiting step
in glutathione synthesis, was added to the cultured cells for
24 hours prior to the experiment at 100 or 1000 mM.
Briefly, following treatments 29,79-dichlorodihydrofluorescein
diacetate (final concentration 10 mM for TE-8 cells; 1 mM or
0.1 mM for NE1 cells) was added and cells incubated at 37uC for
30 minutes in the dark. Cells were detached by trypsinisation,
pelleted by centrifugation and resuspended in PBS. Sample
fluorescence intensity was analysed (FITC channel) using a
FACScaliburTM flow cytometry (Becton Dickinson) and Cell-
QuestTM Pro software (Becton Dickinson). Cells without
fluorescent dye were used as a negative control to correct for
background autofluorescence.
Wound Healing Assay
NE1 oesophageal keratinocyte cells and CCD-18Co colonic
myofibroblasts were grown in twelve-well plates, and subjected to
RNAi knockdown of CYGB as previously described, using both
Ambion and Qiagen siRNAs to CYGB, and a scrambled control
siRNA. Each condition was replicated six times for each cell line.
The cell layer was scratched in a cross shape using a sterile pipette
tip at 24 hours post-knockdown. Cells were photographed at 1, 25
and 50 hours post-wounding using a USB digital camera. Images
were analysed using TScratch software [50], which analysed
alterations in the percentage of Open Wound Area (OWA).
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